Parnell Pharmaceuticals Holdings Ltd. (PARNF)

[MaineMan5]

I totally agree, and if I recall, I don't think PARNF was originally intending to use Zydax on humans, as it is currently in use in many other countries for animals. Would be a great kicker if they could get it approved for humans though. While that would take longer (they have mentioned possible partnerships before) to get approval for humans, I still think the animal business alone is worth at least 10 times more than current share price. They have valued their lab alone at around $50 million, or about $2.75 share. I also have a stake in KIN, which expects one approval by end of year and one by mid next year, has a great mgt team, and 20 drugs in pipeline. Good overview of company from their Sept 27 investor presentation:
https://seekingalpha.com/article/4109903-kindred-biosciences-kin-presents-ladenburg-thalmann-2017-healthcare-conference-slideshow